SAC Capital Advisors LP - AVANIR PHARMACEUTICALS INC ownership

AVANIR PHARMACEUTICALS INC's ticker is AVNR and the CUSIP is 05348P401. A total of 100 filers reported holding AVANIR PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
SAC Capital Advisors LP ownership history of AVANIR PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2014$95,000
+28.4%
25,798
+16.9%
0.00%
Q4 2013$74,000
+21.3%
22,061
+52.1%
0.00%
Q3 2013$61,00014,5000.00%
Other shareholders
AVANIR PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Tyrus Capital S.A.M. 2,295,000$38,900,0006.85%
Baker Brothers Advisors 38,513,713$652,807,0006.66%
Realm Partners LLC 300,000$5,085,0003.92%
Miura Global Management 2,758,000$46,748,0003.52%
WATER ISLAND CAPITAL LLC 10,612,846$179,887,740,0003.00%
LONGFELLOW INVESTMENT MANAGEMENT CO LLC 641,056$10,866,0002.72%
Verition Fund Management LLC 703,900$11,931,0002.67%
GLAZER CAPITAL, LLC 1,004,815$17,032,0002.46%
GARDNER LEWIS ASSET MANAGEMENT L P 716,994$12,153,0002.45%
Rock Springs Capital Management LP 1,100,000$18,645,0002.18%
View complete list of AVANIR PHARMACEUTICALS INC shareholders